🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Outcomes for patients with severe aplastic anemia (SAA) who are refractory ...
Status
Recruiting
Location
CHU Amiens
Start Date
2022-01-06
Trial ID
NCT05126849
Treatments Being Tested
The objective of the study is to assess the effect of standard versus aggre...
Status
Completed
Location
Charles Drew University
Start Date
2005-07
Trial ID
NCT00907374
Treatments Being Tested
This is a phase II trial using a non-myeloablative cyclophosphamide/ fludar...
Status
Completed
Location
Masonic Cancer Center at University of Minnesota
Start Date
2017-03-09
Trial ID
NCT02661035
Mucositis is a common and clinically significant side effect of both antica...
Status
Unknown
Location
Hospital
Start Date
2023-07-17
Trial ID
NCT05871333
Treatments Being Tested
To provide elotuzumab treatment for single-patient use....
Status
No Longer Available
Location
Icahn School.of Medicine at Mount Sinai
Start Date
TBD
Trial ID
NCT02541643
Treatments Being Tested
This study is being done to determine the efficacies of two preventative dr...
Status
Completed
Location
The Ohio State University Wexner Medical Center
Start Date
2007-06
Trial ID
NCT01474915
Treatments Being Tested
The primary hypothesis is that titration of ACE inhibitor and Angiotensin R...
Status
Completed
Location
University of Alabama at Birmingham
Start Date
2007-03
Trial ID
NCT00446862
The purpose of this study is to determine if using an over-the-counter, com...
Status
Completed
Location
UAB Highlands Hospital
Start Date
2018-10-01
Trial ID
NCT03485183
Treatments Being Tested
Belatacept is an experimental medication shown in clinical trials to have i...
Status
Terminated
Location
University of California, San Francisco
Start Date
2006-12
Trial ID
NCT00346151
Treatments Being Tested
The purpose of this study is to evaluate efficacy and safety of Irbesartan ...
Status
Completed
Location
Severance Hospital
Start Date
2022-07-05
Trial ID
NCT05476354
Treatments Being Tested